Cargando…

Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug‐Target Mendelian Randomization Study

BACKGROUND: PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors are important therapeutic options for reducing cardiovascular disease risk; however, questions remain regarding potential differences in the neuropsychiatric impact of long‐term PCSK9 inhibition between men and women. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, Andrew S., Rosoff, Daniel B., Mavromatis, Lucas A., Jung, Jeesun, Wagner, Josephin, Lohoff, Falk W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673626/ https://www.ncbi.nlm.nih.gov/pubmed/36285785 http://dx.doi.org/10.1161/JAHA.122.026122

Ejemplares similares

Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries
por: Rosoff, Daniel B., et al.
Publicado: (2023)

Multi-omic underpinnings of epigenetic aging and human longevity
por: Mavromatis, Lucas A., et al.
Publicado: (2023)

Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging
por: Rosoff, Daniel B., et al.
Publicado: (2023)

Association Between Brain Structure and Alcohol Use Behaviors in Adults: A Mendelian Randomization and Multiomics Study
por: Mavromatis, Lucas A., et al.
Publicado: (2022)

Educational attainment impacts drinking behaviors and risk for alcohol dependence: results from a two-sample Mendelian randomization study with ~780,000 participants
por: Rosoff, Daniel B., et al.
Publicado: (2019)

Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis
por: Rosoff, Daniel B., et al.
Publicado: (2020)

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
por: Fang, Si, et al.
Publicado: (2023)

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
por: O’Connell, Emma M., et al.
Publicado: (2020)

Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization
por: Aman, Alisha, et al.
Publicado: (2022)

Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study
por: Rosoff, Daniel B., et al.
Publicado: (2020)

Educational attainment reduces the risk of suicide attempt among individuals with and without psychiatric disorders independent of cognition: a bidirectional and multivariable Mendelian randomization study with more than 815,000 participants
por: Rosoff, Daniel B., et al.
Publicado: (2020)

TU87. A GENETICALLY-INFORMED EVALUATION OF THE RELATIONSHIPS BETWEEN TOBACCO SMOKING, CANNABIS USE, ALCOHOL CONSUMPTION, AND RESPIRATORY INFECTIONS, INCLUDING COVID-19
por: Yoo, Joyce, et al.
Publicado: (2021)

PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study
por: Lyall, Donald M., et al.
Publicado: (2021)

PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
por: Lee, Ji Soo, et al.
Publicado: (2021)

A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19
por: Rosoff, Daniel B., et al.
Publicado: (2021)

Smoking is significantly associated with increased risk of COVID-19 and other respiratory infections
por: Rosoff, Daniel B., et al.
Publicado: (2021)

Association of High-Intensity Binge Drinking With Lipid and Liver Function Enzyme Levels
por: Rosoff, Daniel B., et al.
Publicado: (2019)

Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study
por: Park, Sehoon, et al.
Publicado: (2023)

PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
por: Lee, Ji Soo, et al.
Publicado: (2019)

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
por: Schmidt, Amand F, et al.
Publicado: (2017)

Epigenetics of alcohol use disorder—A review of recent advances in DNA methylation profiling
por: Longley, Martha J., et al.
Publicado: (2021)

Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder
por: Lohoff, Falk W., et al.
Publicado: (2017)

Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization
por: Chang, Ya-Ching, et al.
Publicado: (2023)

Alcohol use disorder is associated with DNA methylation-based shortening of telomere length and regulated by TESPA1: implications for aging
por: Jung, Jeesun, et al.
Publicado: (2022)

Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2
por: Luo, Audrey, et al.
Publicado: (2019)

Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
por: Xie, Weijia, et al.
Publicado: (2023)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer
por: Sun, Lulu, et al.
Publicado: (2022)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

A Mendelian randomization study of testosterone and cognition in men
por: Zhao, Jie V., et al.
Publicado: (2016)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
por: Benn, Marianne, et al.
Publicado: (2017)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
Publicado: (2017)

The major depressive disorder GWAS-supported variant rs10514299 in TMEM161B-MEF2C predicts putamen activation during reward processing in alcohol dependence
por: Muench, Christine, et al.
Publicado: (2018)

The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women
por: Evans, David, et al.
Publicado: (2006)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7i0ppkhq5ctbnpoa5dbav5qv73